Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Disseminated Intravascular Coagulation

• A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.
• A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
• Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery
• Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study
• LD-FUD for Highly Aggressive Gastric Cancer
• The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
• Patient Blood Management for Massive Obstetric Hemorrhage
• Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
• Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
• An Open-label Study of KW-3357
• A Phase 3 Clinical Study of KW-3357 in Patients With DIC
• A Clinical Study of KW-3357 in Patients With DIC
• Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
• Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis
• Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation